Carcinogenesis · 1987 · 72 citations · 0 references
PharmacyPharmacologyToxicologyCarcinogenesisMechanisms Of ToxicityMolecular ToxicologyCarcinogen MetabolismCarcinogenic MechanismsCarcinogenicity AssessmentChemical CarcinogenesisGenotoxicity MechanismsMutagenicity AssessmentAromatic HydrocarbonsChemical Mutagen SafetyMechanisms Of CarcinogenicityMutagenic MechanismsPolycyclic Aromatic Hydrocarbon CarcinogenesisPolycyclic Aromatic Hydrocarbon GenotoxicityPolycyclic Aromatic Hydrocarbon ToxicologyPolycyclic Aromatic Hydrocarbons
Dependence of polycyclic aromatic hydrocarbon (PAH)-induced mutagenicity on the bay region of the molecule and on the activating cytochrome P-450 enzyme was studied. Eleven PAHs with and six without a bay region were activated by postmitochondrial supernatants from control and 3-methylcholanthrene (MC)-pretreated C57BL/6 mice and from control, MC- and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-pretreated DBA/2 mice and from control and MC-pretreated Sprague-Dawley and Lewis rats. S-9 fractions from MC- or TCDD-treated animals induced more mutagenicity with PAHs with a bay region compared with S-9 fractions from control animals or MC-treated D2 mice. Mutagenicities of PAHs without a bay region were largely independent of the source of activating enzyme. There were three exceptions, namely benzo[e]pyrene, phenanthrene and perylene (each possessing a bay region), which were not mutagenic. These studies support the notion that the Ah-locus-controlled induction of cytochrome P1-450 activating PAHs into reactive intermediates at the bay region of the hydrocarbon molecule is of prime importance in the mutagenicity of PAHs. Qualitative correspondence to carcinogenicity is also apparent.